Men's Health
Urology Basket

Urology basket for bladder pain, overactive bladder, benign prostatic hyperplasia, urinary urgency and lower urinary tract symptoms.

Pentosan Polysulfate SodiumMirabegronTamsulosinSilodosinDutasterideVibegronFinasteride

The conditions men live with, but rarely speak about.

Lower urinary tract symptoms are among the most prevalent — and most under-discussed — health challenges facing men from their fourth decade onwards. What begins as an inconvenience becomes, over years, a measurable loss of confidence, sleep, and independence.

Our urology portfolio maps the therapeutic journey from early symptom management through combination disease modification and bladder-specific intervention — following the evidence at every stage.

40s

typical onset

The Silent Warning

It begins with something easy to dismiss — a slower stream, a late-night trip to the bathroom, a hesitation that wasn't there before. Benign Prostatic Hyperplasia (BPH) affects over 50% of men by age 60. Most wait years before seeking care.

Mechanism

Alpha-1 blockers relax smooth muscle in the prostate and bladder neck, restoring urinary flow within days of initiation.

Portfolio molecules

TamsulosinSilodosin

50s

typical onset

Managing the Progression

Symptom control is not disease control. As the prostate continues to enlarge, alpha-blockers alone are no longer enough. The evidence points clearly toward combination therapy — addressing both the symptom and the structural cause simultaneously.

Mechanism

5-alpha reductase inhibitors (Dutasteride, Finasteride) reduce DHT-driven prostate volume by 20–30% over 6–12 months. Combination with alpha-blockers delivers synergistic, sustained benefit.

Portfolio molecules

Tamsulosin + DutasterideSilodosin + DutasterideTamsulosin + Finasteride

60s+

typical onset

Restoring Quality of Life

Overactive bladder and urge incontinence are not prostate problems — they are bladder problems. For the millions of men (and women) whose bladder signals have become ungovernable, a different mechanism entirely is needed.

Mechanism

Beta-3 adrenergic agonists (Mirabegron) work on the detrusor muscle — relaxing the bladder during filling. Unlike antimuscarinics, they carry no cognitive side-effect burden in older patients.

Portfolio molecules

MirabegronMirabegron + Solifenacin

50%+

of men over 60 have BPH symptoms

₹2,667 Mn

SSPL urology portfolio — MAT Mar 2026

2 segments

BPH & Urinary Incontinence